Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 3,667 shares at $153.75 ($575K) on 2024-06-18, disclosed to the SEC on 2024-06-20.
Seasonal sale ($575k) by Global Head of R&D — this insider has traded BGNE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.50 | 237 | $38K | 6.5% |
| 2 | $159.00 | 478 | $76K | 13.2% |
| 3 | $159.42 | 485 | $77K | 13.5% |
| 4 | $159.42 | 485 | $77K | 13.5% |
| 5 | $159.90 | 300 | $48K | 8.3% |
| 6 | $153.75 | 841 |
| $129K |
| 22.5% |
| 7 | $153.75 | 841 | $129K | 22.5% |
| Total | $156.74 avg | 3,667 | $575K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |